Login

Simone Veglioni discusses VANTEA SMART while EGOMNIA S.p.A. details strengths and projects in an online IPO talk. 00:10:00

Share On Facebook Share On Twitter

Simone Veglioni ceo of Vantea SMART S.p.A

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Aspen Pharmacare CEO Stephen Saad is featured in the C-Suite, providing insights into the company’s top-level strategy and leadership.
00:10:00
Aotearoa's Biggest Airport Set for Revamp: What It Means for Us All | Carrie Hurihanganui - CEO of auckland international airport ltd
00:10:00
Interview with Nick from Taurus Fund Management: Insights from the 1-2-1 Conference
00:10:00
Yie-Hsin Hung on Leadership with Purpose: Building Successful Teams, Embracing Diversity, and Empowering Women in Finance
00:10:00
CEO Jessica Skon Highlights BTS Group's Record Quarter in Discussion with Equity Analyst Rikard Engberg | Jessica Skon - CEO of BTS group
00:10:00
Fury Gold Mines: Advancing High-Grade Gold Projects in Canada
00:10:00
Culpeo Minerals Expands Land Package at Fortuna Copper Project | Max Tuesley, Managing Director , Culpeo Mineral Plc.
00:10:00
where it currently exists versus Where the world is headed |Peter C. Lewis,CHAIRMAN,Wharton Equity Partners
00:10:00
Understanding Active External Engagement: AXA IM for Progress Monitor - Olivier Eugene
00:10:00
Invests in technical founders building the next generation|Sunil Dhaliwal,Founder and General Partner,Amplify Partners
00:10:00
Silver Lake's Revised Proposal for St. Barbara Sparks Shareholder Interest Amid Hostile Deal
00:10:00
Inside All for One Steeb. Interview mit Serkar | Lars Landwehrkamp, CEO, All for One Group SEA1OSX:GER

© 2017 - Neuhu+